MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
CareDx, Inc Operating Expenses 2011-2025 | CDNA
Annual Operating Expenses CareDx, Inc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 484 M | 399 M | 326 M | 215 M | 106 M | 58.1 M | 44.1 M | 44.3 M | 29.9 M | 18.8 M | 13.9 M | 14.9 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 484 M | 13.9 M | 146 M |
Quarterly Operating Expenses CareDx, Inc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 M | 97.8 M | 98.1 M | - | 96.6 M | 99.6 M | 94.6 M | - | 96 M | 97.9 M | 102 M | - | 96.7 M | 102 M | 98.5 M | - | 84.3 M | 78.9 M | 68.3 M | - | 56.3 M | 52.6 M | 44.1 M | - | 40.6 M | 26.8 M | 21.6 M | - | 15 M | 15.8 M | 19.3 M | - | 16.1 M | 15.6 M | 20.1 M | - | 17.4 M | 17.7 M | 13.1 M | - | 10.3 M | 10 M | 8.61 M | - | 5.26 M | 7.12 M | 6.15 M | - | 6.14 M | 5.71 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 102 M | 5.26 M | 49 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.0 | -1.91 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.7 | -2.24 % | $ 223 M |  China |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.23 | -3.87 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 39.2 | -0.51 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 230.43 | 0.05 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.56 | 5.18 % | $ 300 M | Israel |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.51 | -0.95 % | $ 1.92 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.85 | 0.28 % | $ 18.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
1.69 B | $ 67.71 | 0.21 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Celcuity
CELC
|
113 M | $ 101.24 | -0.99 % | $ 3.99 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.19 | -0.47 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 226.71 | -0.09 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
226 M | $ 101.95 | -1.01 % | $ 12.5 B | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.23 | 1.4 % | $ 1.57 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.35 | -2.01 % | $ 575 M | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.92 | 1.39 % | $ 464 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.81 | -5.39 % | $ 2.58 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.26 | 0.55 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
44.5 M | $ 8.05 | -1.11 % | $ 477 M | USA |
 |
Quidel Corporation
QDEL
|
285 M | $ 29.14 | -0.56 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 133.97 | -0.73 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 203.01 | -0.32 % | $ 10.4 B | USA |
 |
RadNet
RDNT
|
1.73 B | $ 73.05 | -0.14 % | $ 5.34 B | USA |
 |
Soleno Therapeutics
SLNO
|
188 M | $ 47.74 | 0.19 % | $ 1.92 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 175.29 | -0.37 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.73 | -1.32 % | $ 873 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 252.89 | -0.39 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 182.85 | 0.01 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 683.4 | -0.74 % | $ 56.4 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 67.01 | 0.45 % | $ 4.64 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 413.2 | -0.49 % | $ 30 B |  Schweiz |